Valproate: Clinical Trials

56 trials of Valproate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 8 unknown, 7 terminated, 4 recruiting. 14 Phase 4, 13 Phase 3, 12 Phase 2, 11 Phase 1, 8 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 414Completed 7, Terminated 3, Unknown 3, Withdrawn 1
Phase 313Completed 9, Recruiting 3, Unknown 1
Phase 212Completed 5, Recruiting 3, Active not recruiting 1, Suspended 1, Unknown 1, Withdrawn 1
Phase 111Completed 7, Terminated 2, Recruiting 1, Suspended 1
Not applicable8Completed 5, Unknown 2, Terminated 1
Early Phase 11Completed 1

Follow Valproate: new trials by email Literature Review of Valproate trials Research Report on Valproate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Valproate for the Treatment of Residual Amblyopia
Valproate, Placebo, Patch - Amblyopia, Amblyopia Unilateral
Phase 1 / Phase 2RecruitingBoston Children's Hospital282026-07-012026-07-30
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
KarXT, Lithium, Valproate - Bipolar Disorder Type I With Mania
Phase 3RecruitingBristol-Myers Squibb4502025-07-182026-09-14
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
Phenobarbital Sodium Injection, Levetiracetam, Lacosamide Injectable Product - Brain Injuries, Acute, Brain Injuries, Traumatic
Phase 4TerminatedUniversity of North Carolina, Chapel Hill52023-11-202025-11-14
Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
Valproate, Quetiapine, Standard of Care - Covid19, Hyperactive Delirium
Phase 4WithdrawnUniversity of Miami2023-03-282023-03-31
Zolmitriptane as Prophylaxis for Chilhood Migraine
zolmitriptanee, topiramate, Valproate - Migraine
Phase 4UnknownTanta University902023-01-012023-10-18
Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
Haloperidol, Chlorpromazine, Valproate - Delirium, Epileptics
Phase 2 / Phase 3RecruitingM.D. Anderson Cancer Center422022-07-192025-11-18
Lithium Versus Anticonvulsants and the Risk of Physical Disorders
Lithium - Bipolar Disorder
CompletedMental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital1692852022-06-012023-08-22
Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate
Mefanamic Acid, Valproate - Drug Drug Interaction
Phase 1CompletedHaisco Pharmaceutical Group Co., Ltd.412021-12-172022-07-14
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
Neratinib, Divalproex Sodium - Solid Tumor, Adult
Phase 1 / Phase 2SuspendedVirginia Commonwealth University802019-05-012026-10-21
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
sodium valproate with Clozapine, modified electroconvulsive therapy(MECT) with Clozapine, amisulpride with Clozapine - Schizophrenia
Phase 4CompletedShanghai Mental Health Center1452018-09-062022-09-06
Sleep Architecture in Valproate-induced Nocturnal Enuresis in Primary School and Preschool Children.
Clinical, EEG and laboratory assessment at presentation, Valproate - Epilepsy, Nocturnal Enuresis
CompletedMansoura University Hospital2602018-09-012020-05-07
Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures
Levetiracetam, Valproate - Epilepsy, Idiopathic Generalized
Phase 4CompletedMazandaran University of Medical Sciences1032018-04-012022-02-17
Assessment of Valproate on Ethanol Withdrawal
Valproate, Lorazepam - Alcohol Dependence, Alcohol Withdrawal Syndrome
Phase 4TerminatedCAMC Health System32017-07-112026-08-18
Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus
Phenobarbital, Valproate - Generalized Convulsive Status Epilepticus
Phase 2UnknownXuanwu Hospital, Beijing1202017-02-162019-07-09
The Optimal Treatment for Treatment-resistant Schizophrenia
Risperidone with Clozapine, Aripiprazole with Clozapine, sodium valproate with Clozapine - Schizophrenia
Not applicableUnknownShanghai Mental Health Center1502016-11-012019-03-13
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Lithium Carbonate, Lamotrigine, Valproic Acid - Bipolar Disorder
TerminatedUniversity of New Mexico10373522016-09-012024-03-12
A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures
Valproate - Epilepsy
Phase 1 / Phase 2CompletedCerebral Therapeutics LLC62016-08-012023-03-16
Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
Stereotactic Radiosurgery, Nivolumab, Valproate - Glioblastoma
Phase 1TerminatedUniversity of Virginia42016-05-242017-05-31
Cytidine- and Creatine-Containing Drug in Treating Bipolar Depression
Valproate+Cytidine-+Creatine-, Valproate+Cytidine-, Valproate - Bipolar Depression
Phase 2WithdrawnEwha Womans University2015-12-012018-02-09
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
Dexamethasone, Laboratory Biomarker Analysis, Valproic Acid - Adnexal Mass, Borderline Ovarian Epithelial Tumor
Phase 1CompletedBarbara Ann Karmanos Cancer Institute502015-08-012019-08-14

Showing 20 of 56. Sign in to see all of them.

Conditions studied

Bipolar Disorder (12)  ·  Mania (5)  ·  Schizophrenia (4)  ·  Epilepsy (3)  ·  Status Epilepticus (3)  ·  Alcoholism (2)  ·  Brain Injuries, Traumatic (2)  ·  Brain Neoplasms (2)  ·  Heart Arrest (2)  ·  Hypoxia, Brain (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Lymphoma (2)  ·  Migraine Disorders (2)  ·  Psychomotor Agitation (2)  ·  Psychotic Disorders (2)

Sponsors

M.D. Anderson Cancer Center (3)  ·  Lund University Hospital (2)  ·  Shanghai Mental Health Center (2)  ·  University of Miami (2)  ·  Washington University School of Medicine (2)  ·  All India Institute of Medical Sciences (1)  ·  Alzheimer's Disease Cooperative Study (ADCS) (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Boston Children's Hospital (1)  ·  Bristol-Myers Squibb (1)  ·  CAMC Health System (1)  ·  Centre Leon Berard (1)  ·  Cerebral Therapeutics LLC (1)  ·  Eli Lilly and Company (1)  ·  Emory University (1)

Countries

United States (26)  ·  China (6)  ·  France (4)  ·  Sweden (4)  ·  Denmark (3)  ·  Italy (3)  ·  Spain (3)  ·  Australia (2)  ·  Austria (2)  ·  Belgium (2)  ·  Canada (2)  ·  Czechia (2)  ·  Egypt (2)  ·  Germany (2)  ·  Hungary (2)

Top investigators

.Vasu Chantarasak, MD (1)  ·  Abeer Salamah, ass prof (1)  ·  Amadeo Alinea (1)  ·  Andree Daigneault, Dr. (1)  ·  Andrew Poklepovic, MD (1)  ·  Audis Bethea, PharmD, BCPS (1)  ·  Ayal Schaffer, Dr. (1)  ·  Barbara Geller, MD (1)  ·  Barry Ruijter, MD (1)  ·  Benjamin Purow, MD (1)  ·  Benny Lafer, Dr. (1)  ·  Boadie W Dunlop, MD (1)

Results publications

PMID 11765093, PMID 15005752, PMID 15110730, PMID 15330403, PMID 15349007, PMID 15465989, PMID 15541061, PMID 15569893, PMID 15677618, PMID 15723025, PMID 15898966, PMID 15950022, PMID 15960566, PMID 16023735, PMID 16168792, PMID 16176440, PMID 16197928, PMID 16338761, PMID 16339615, PMID 16339616, PMID 16426088, PMID 16448626, PMID 16449473, PMID 16449474, PMID 16552982, PMID 16566627, PMID 16595351, PMID 16635643, PMID 16675760, PMID 16677228, PMID 16816280, PMID 16816301, PMID 16928441, PMID 17007487, PMID 17042830, PMID 17107609, PMID 17335331, PMID 17392295, PMID 17404119, PMID 17582828, PMID 17728418, PMID 18227782, PMID 18399724, PMID 18681768, PMID 19210946, PMID 20148867, PMID 20409444, PMID 21176032, PMID 21360754, PMID 21810649

NIH funding

1RC2AG036535 (1), K08MH001516 (1), K23MH067795 (1), K23NS058669 (1), P30CA022453 (1), R01DA019992 (1), U01MH064846 (1), U01MH064850 (1), U01MH064868 (1), U01MH064869 (1), U01MH064887 (1), U01MH064911 (1), U01MH068847 (1)